EUVIMEDDescobrir EUVIMED
Crossref

Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance

Hayfa Abdullah Al-Olayan

Journal of Pioneering Medical Sciences · 2026-07-05 · 15 (6) · 132-137

DOI: 10.47310/jpms2026150617 ↗

At a glance

Journal article in Journal of Pioneering Medical Sciences, published online on 2026-07-05. Written by Hayfa Abdullah Al-Olayan.

ResumoDados bibliográficosCiteRelated studies

Abstract (original language)

Papillary Thyroid Microcarcinoma (PTMC), defined as papillary thyroid carcinoma ≤1 cm, accounts for an increasing share of thyroid cancer diagnoses worldwide. Although generally indolent, a subset exhibits aggressive clinicopathological features, including multifocality, extrathyroidal extension and lymph node metastasis, which complicate risk stratification and treatment. To summarize the current evidence regarding the prognostic significance of multifocality in PTMC, its underlying pathogenetic mechanisms and the evolving role of Active Surveillance (AS) versus surgical management.

Methods

This narrative review integrates epidemiological, molecular, guideline and outcome data to outline a risk-adapted approach. Evidence was identified through a non-systematic literature search and no formal systematic-review or quantitative synthesis methodology was applied; findings should therefore be interpreted in this context. Institutional review board approval and informed consent were not required for this review of previously published literature.

Results

Multifocality occurs in 20-36% of papillary thyroid carcinomas and may arise from independent multicentric tumorigenesis or intrathyroidal clonal spread. Observational evidence has associated multifocality with an increased risk of recurrence in some, though not all, studies, particularly when combined with tumor size ≥6 mm, nodal involvement, or aggressive histologic variants; its independent effect on disease-specific mortality is less certain. Although AS is endorsed for selected low-risk PTMC, eligibility criteria vary internationally, especially for multifocal disease. The extent of surgery remains individualized.

Conclusion

PTMC management should follow a risk-adapted strategy that integrates tumor focality, pathological features and patient factors to avoid overtreatment and undertreatment.

Cite

APA

Al-Olayan, H. A. (2026). Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance. Journal of Pioneering Medical Sciences, 15(6), 132-137. https://doi.org/10.47310/jpms2026150617

Vancouver

Al-Olayan HA. Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance. Journal of Pioneering Medical Sciences. 2026;15(6):132-137. doi:10.47310/jpms2026150617

BibTeX
@article{AlOlayan2026,
  author = {Al-Olayan, Hayfa Abdullah},
  title = {Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance},
  journal = {Journal of Pioneering Medical Sciences},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {132--137},
  doi = {10.47310/jpms2026150617}
}
Start for free →